Komori
Pharma Foods International (2929) · InitiativeAdvanced

Joint development of HGP, a novel hair-growth active ingredient

First written in FY2016-Q3. 7 of 14 entries say "Restated". Latest entry: FY2021.

14entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q2 – FY2018-Q1AdvancedFY2020-Q3 – FY20212016: 220162017: 320172018: 320182019: 420192020: 120202021: 12021
Same theme, other companies
Joint Development and Commercialization of the New Hair-Growth-Active Ingredient HGPA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021AdvancedAnnual report

    「HGP®, a hair-growth ingredient, generated revenue of ¥50 million, up 217.7% year on year, as demand increased, particularly in China, following strong recognition of the domestic No. 1 market-share performance of the Company's Neumo® hair-growth product.」

    Demand for HGP increased in China against the backdrop of Neumo's No. 1 domestic market-share performance, resulting in revenue of ¥50 million, up 217.7% year on year.
  2. FY2020-Q3AdvancedAnnual report

    「The Company will continue to expand its range of hair-care and scalp-care products using its functional ingredient HGP®.」

    HGP-related product development is expanding beyond existing manufacturer adoption and sales to include a broader range of hair-care and scalp-care products.
  3. FY2020-Q1RestatedAnnual report

    「HGP® (Hair Growth Peptide, pronounced “H-G-P”), a hair-growth ingredient derived from egg yolk, is attracting interest as a hair-growth ingredient for oral consumption unlike any previously available, and its adoption by health-food manufacturers and others is progressing.」

    The increasing adoption of HGP by health-food manufacturers and others and its commercial development continue to be reported.
  4. FY2019AdvancedAnnual report

    「HGP® 5,932 44,157」

    HGP revenue increased from ¥5.932 million in the previous fiscal year to ¥44.157 million in the current fiscal year, with progress in manufacturer adoption also reflected in sales results.
  5. FY2019-Q3RestatedAnnual report

    「HGP (Hair Growth Peptide), a hair-growth ingredient derived from egg yolk, is being increasingly adopted by distributors, health-food manufacturers and others. It is attracting interest as a hair-growth ingredient for oral consumption unlike any previously available, and efforts will continue to expand its use.」

    The policy of expanding HGP adoption by distributors, health-food manufacturers and others, as well as its commercial development, continues.
  6. FY2019-Q2RestatedAnnual report

    「HGP (Hair Growth Peptide), a hair-growth ingredient derived from egg yolk, is seeing increased adoption by distributors, health food manufacturers and others.」

    The commercial development of HGP and its increasing adoption by manufacturers continue to be reported.
  7. FY2019-Q1AdvancedAnnual report

    「HGP (Hair Growth Peptide), a hair-growth ingredient derived from egg yolk, is being increasingly adopted by distributors, health-food manufacturers and others. It is attracting interest as a hair-growth ingredient for oral consumption unlike any previously available, and efforts will continue to expand its use.」

    For HGP, the description of commercial progress has shifted from sales and OEM orders to increasing adoption by distributors, health-food manufacturers and others.
  8. FY2018-Q3RestatedAnnual report

    「HGP has attracted attention from distributors and health food manufacturers as an ingestible hair-growth ingredient, and the company is focusing on securing OEM orders and pursuing further expansion.」

    Commercial development of HGP, which was jointly developed with CHARLE CO.,LTD., is continuing through sales of existing products and OEM orders.
  9. FY2018-Q2AdvancedAnnual report

    「HGP has attracted attention from distributors and health food manufacturers as an ingestible hair-growth ingredient, and the company is focusing on securing OEM orders and pursuing further expansion.」

    For HGP, which was jointly developed with CHARLE CO.,LTD., orders for OEM products have been reported in addition to sales of existing products, indicating progress in commercial development.
  10. FY2018-Q1RestatedAnnual report

    「In addition, CHARLE CO.,LTD. is selling Bihatsunes, a supplement containing HGP (Hair Growth Peptide), a novel hair-growth active ingredient derived from egg yolk.」

    Sales of HGP-containing supplements jointly developed with CHARLE CO.,LTD. are ongoing.
  11. FY2017-Q3RestatedAnnual report

    「In addition, CHARLE CO.,LTD. is selling Bihatsunes, a supplement containing HGP (Hair Growth Peptide), a novel hair-growth active ingredient derived from egg yolk, which is attracting attention as a new hair-growth ingredient.」

    Sales of HGP-containing supplements jointly developed with CHARLE CO.,LTD. and their continued development as a new ingredient are ongoing.
  12. FY2017-Q2RestatedAnnual report

    「Among the new products launched is Bihatsunes, a women's supplement containing HGP (Hair Growth Peptide), a novel hair-growth active ingredient derived from egg yolk and jointly developed with CHARLE CO.,LTD.」

    The launch of HGP-containing products jointly developed with CHARLE CO.,LTD. and the development and sales strategy have been reaffirmed.
  13. FY2017-Q1AdvancedAnnual report

    「In terms of development, a women’s supplement called “Bihappiness,” formulated with HGP (Hair Growth Peptide), a novel egg-yolk-derived hair-growth active ingredient jointly developed with CHARLE CO.,LTD., has been newly launched.」

    A product containing HGP, the result of joint development with CHARLE CO.,LTD., was newly launched, marking progress from development to commercialization.
  14. FY2016-Q3First statedAnnual report

    「In terms of development, we jointly developed the novel hair-growth active ingredient “HGP (Hair Growth Peptide)” with CHARLE CO.,LTD. and jointly presented the results at the Japan Society for Bioscience, Biotechnology, and Agrochemistry.」

    Progress has been made through joint development with an external company and presentation at an academic conference.
Moved together

"Commercialization and Development Pipeline for New Functional Materials" moved the same way as this thread, in the same document, in 6 of its 14 moves.

654443★123456
  1. ★This thread
  2. 1Commercialization and Development Pipeline for New Functional Materials6×
  3. 2 적극ive efforts under the Foods with Function Claims system5×
  4. 3Advertising Investment and Product Brand Expansion in Mail-Order Sales4×
  5. 4Guarantee Obligations to Affiliates and Business Partners4×
  6. 5Functional Materials business: lower revenue and profit4×
  7. 6GABA Expansion in Japan and Overseas3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Joint development of HGP, a novel hair-growth active ingredient | Pharma Foods International Co.,Ltd. (2929) | Komori